Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]-GP1 PET Imaging for Thrombus Detection
NCT02469376Phase 1Terminated
- Sponsor
- University of Zurich
- Start
- Sep 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 18F-GP1 in abdominal aortic aneurysm (AAA) and deep vein thrombosis (DVT), sponsored by University of Zurich. Primary endpoint: Assessment of biodistribution of [18F]-GP1 at 12 months. Started Sep 2014; status: terminated.
02
Drugs
18F-GP1
03
Conditions
abdominal aortic aneurysm (AAA)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT02469376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02469376.